The trajectory of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated massive profits, the expiration of its exclusive rights opened the floodgates to cheaper versions, https://pr8bookmarks.com/story21763876/viagra-and-big-pharma-a-precarious-bet